485 related articles for article (PubMed ID: 3019018)
1. [Activation of the macrophage/lymphocyte system in AIDS, ARC and AIDS risk groups].
Wachter H; Blecha HG; Fuchs D; Hausen A; Hengster P; Hinterhuber H; Reibnegger G; Reissigl H; Rössler H; Schönitzer D
Wien Klin Wochenschr; 1986 Jul; 98(14):449-54. PubMed ID: 3019018
[TBL] [Abstract][Full Text] [Related]
2. Activated T cells in addition to LAV/HTLV-III infection: a necessary precondition for development of AIDS.
Fuchs D; Hausen A; Hoefler E; Schönitzer D; Werner ER; Dierich MP; Hengster P; Reibnegger G; Schulz T; Wachter H
Cancer Detect Prev Suppl; 1987; 1():583-7. PubMed ID: 3500785
[TBL] [Abstract][Full Text] [Related]
3. Clinical and immunological findings in HTLV-III infection.
Krohn KJ; Antonen J; Valle SL; Kazakevicius R; Saxinger C; Gallo RC; Ranki A
Cancer Res; 1985 Sep; 45(9 Suppl):4612s-4615s. PubMed ID: 2990694
[TBL] [Abstract][Full Text] [Related]
4. Implications of the discovery of HTLV-III for the treatment of AIDS.
Yarchoan R; Mitsuya H; Matsushita S; Broder S
Cancer Res; 1985 Sep; 45(9 Suppl):4685s-4688s. PubMed ID: 2410113
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV.
Folks T; Kelly J; Benn S; Kinter A; Justement J; Gold J; Redfield R; Sell KW; Fauci AS
J Immunol; 1986 Jun; 136(11):4049-53. PubMed ID: 2422271
[TBL] [Abstract][Full Text] [Related]
6. AIDS and the spectrum of HTLV-III/LAV infection.
Pinching AJ; Weiss RA
Int Rev Exp Pathol; 1986; 28():1-44. PubMed ID: 2870992
[No Abstract] [Full Text] [Related]
7. The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells.
Schechter MT; Boyko WJ; Jeffries E; Willoughby B; Nitz R; Constance P; Weaver M; Wiggs B; O'Shaughnessy M
Can Med Assoc J; 1985 Aug; 133(4):286-92. PubMed ID: 2990652
[TBL] [Abstract][Full Text] [Related]
8. [Acquired immune deficiency syndrome (AIDS)].
Drusin LM; Stingl G
Z Hautkr; 1985 Sep; 60(18):1432-60. PubMed ID: 2998109
[TBL] [Abstract][Full Text] [Related]
9. HTLV-III/LAV antibody and immune status of household contacts and sexual partners of persons with hemophilia.
Jason JM; McDougal JS; Dixon G; Lawrence DN; Kennedy MS; Hilgartner M; Aledort L; Evatt BL
JAMA; 1986 Jan; 255(2):212-5. PubMed ID: 3001375
[TBL] [Abstract][Full Text] [Related]
10. [Kaposi sarcoma within the scope of AIDS].
Meigel W; Kern P; Dietrich M
Z Hautkr; 1986 May; 61(9):626-8, 633-4. PubMed ID: 3012897
[TBL] [Abstract][Full Text] [Related]
11. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
[TBL] [Abstract][Full Text] [Related]
12. [Diagnosis and therapy of pneumocystis carinii pneumonia in a patient with AIDS].
Schur W; Asamer H
Wien Klin Wochenschr; 1986 Mar; 98(5):137-41. PubMed ID: 3008447
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of lymphocyte subset analysis in AIDS case finding.
Boyko WJ; Schechter MT; MacLeod A; Douglas B; Maynard M; Sharp R; Wiggs B
CMAJ; 1986 May; 134(9):1013-7. PubMed ID: 2938707
[TBL] [Abstract][Full Text] [Related]
14. AIDS--an immunologic reevaluation.
Seligmann M; Chess L; Fahey JL; Fauci AS; Lachmann PJ; L'Age-Stehr J; Ngu J; Pinching AJ; Rosen FS; Spira TJ
N Engl J Med; 1984 Nov; 311(20):1286-92. PubMed ID: 6092954
[No Abstract] [Full Text] [Related]
15. [Immunological changes in HTLV-III infections and AIDS].
Krohn K; Antonen J
Duodecim; 1986; 102(7):413-22. PubMed ID: 2424708
[No Abstract] [Full Text] [Related]
16. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS).
Shearer GM; Bernstein DC; Tung KS; Via CS; Redfield R; Salahuddin SZ; Gallo RC
J Immunol; 1986 Oct; 137(8):2514-21. PubMed ID: 3489767
[TBL] [Abstract][Full Text] [Related]
17. AIDS: what is now known. I. History and immunovirology.
Selwyn PA
Hosp Pract (Off Ed); 1986 May; 21(5):67-76, 81-2. PubMed ID: 3009507
[No Abstract] [Full Text] [Related]
18. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 May; 35(20):334-9. PubMed ID: 3010072
[TBL] [Abstract][Full Text] [Related]
19. Neopterin as discriminating and prognostic parameter in healthy homosexuals, ARC and AIDS patients.
Hutterer J; Fuchs D; Eder G; Hausen A; Knapp W; Köller U; Reibnegger G; Werner ER; Wachter H; Stingl G
Wien Klin Wochenschr; 1987 Aug; 99(15):531-5. PubMed ID: 2958970
[TBL] [Abstract][Full Text] [Related]
20. Immunological findings associated with HTLV-III antibody positivity.
Antonen J
Ann Clin Res; 1985; 17(2):81-5. PubMed ID: 2994542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
